BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26285198)

  • 1. The Trans-Pacific Partnership Agreement: Trading away our health?
    Ruckert A; Schram A; Labonté R
    Can J Public Health; 2015 Apr; 106(4):e249-51. PubMed ID: 26285198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new generation of trade policy: potential risks to diet-related health from the trans pacific partnership agreement.
    Friel S; Gleeson D; Thow AM; Labonte R; Stuckler D; Kay A; Snowdon W
    Global Health; 2013 Oct; 9():46. PubMed ID: 24131595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Regional Comprehensive Economic Partnership, Intellectual Property Protection, and Access to Medicines.
    Townsend B; Gleeson D; Lopert R
    Asia Pac J Public Health; 2016 Nov; 28(8):682-693. PubMed ID: 27920239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts.
    Gleeson D; Lexchin J; Labonté R; Townsend B; Gagnon MA; Kohler J; Forman L; Shadlen KC
    Global Health; 2019 Nov; 15(Suppl 1):78. PubMed ID: 31775767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is health impact assessment useful in the context of trade negotiations? A case study of the Trans Pacific Partnership Agreement.
    Hirono K; Haigh F; Gleeson D; Harris P; Thow AM; Friel S
    BMJ Open; 2016 Apr; 6(4):e010339. PubMed ID: 27044579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health.
    Labonté R; Crosbie E; Gleeson D; McNamara C
    Global Health; 2019 May; 15(1):35. PubMed ID: 31088499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Just Say No to the TPP: A Democratic Setback for American and Asian Public Health Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?".
    Muntaner C; Mahabir DF
    Int J Health Policy Manag; 2017 Jul; 6(7):419-421. PubMed ID: 28812839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Trans-Pacific Partnership: Is It Everything We Feared for Health?
    Labonté R; Schram A; Ruckert A
    Int J Health Policy Manag; 2016 Aug; 5(8):487-496. PubMed ID: 27694662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia.
    Lexchin J; Gleeson D
    Int J Health Serv; 2016 Oct; 46(4):597-613. PubMed ID: 27516183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protecting the autonomy of states to enact tobacco control measures under trade and investment agreements.
    Mitchell A; Sheargold E
    Tob Control; 2015 Jun; 24(e2):e147-53. PubMed ID: 25361743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TPPA and tobacco control: threats to APEC countries.
    Sy DK; Stumberg RK
    Tob Control; 2014 Nov; 23(6):466-70. PubMed ID: 25170023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing Public Health on the Changing Global Trade and Investment Agenda Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?".
    Thow AM; Gleeson D
    Int J Health Policy Manag; 2017 May; 6(5):295-298. PubMed ID: 28812819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Trans-Pacific Partnership: Should We "Fear the Fear"? Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?".
    Walls HL; Hanefeld J; Smith RD
    Int J Health Policy Manag; 2017 Jun; 6(6):353-355. PubMed ID: 28812829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam.
    Moir HVJ; Tenni B; Gleeson D; Lopert R
    Glob Public Health; 2018 Apr; 13(4):400-413. PubMed ID: 27841097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high price of "free" trade: U.S. trade agreements and access to medicines.
    Lopert R; Gleeson D
    J Law Med Ethics; 2013; 41(1):199-223. PubMed ID: 23581666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Models of Investor State Dispute Settlement Are Bad for Health: The European Union Could Offer an Alternative Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?".
    McKee M; Stuckler D
    Int J Health Policy Manag; 2017 Mar; 6(3):177-179. PubMed ID: 28812799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defending access to medicines in regional trade agreements: lessons from the Regional Comprehensive Economic Partnership - a qualitative study of policy actors' views.
    Townsend B
    Global Health; 2021 Jul; 17(1):78. PubMed ID: 34238347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving trade policy and the Trans-Pacific Partnership Agreement: does it threaten Vietnam's access to medicine and its progress towards scaling up HIV prevention, treatment and care?
    Linh NN; Huong NT; Thuy HT
    Glob Public Health; 2015; 10 Supppl 1():S149-60. PubMed ID: 25469870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trade, Labour Markets and Health.
    McNamara C; Labonté R
    Int J Health Serv; 2017 Apr; 47(2):277-297. PubMed ID: 28013576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Health Impact of Trade: A Call for an Expanded Research Agenda Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?".
    McNamara C
    Int J Health Policy Manag; 2017 May; 6(5):293-294. PubMed ID: 28812818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.